Treprostinil is used to treat certain kinds of pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Treprostinil may improve the ability to exercise and slow the worsening of symptoms in patients with PAH. It is grouped under the following drug class(es): Prostaglandins and Vasodilating agents. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include Hexadecyl treprostinil and treprostinil hexadecyl ester. Its PubChem CID is 91617675.
Treprostinil palmitil
| CAS No | 1706528-83-7 |
|---|---|
| Molecular Formula | C39H66O5 |
| Molecular Weight | 614.9 g/mol |
| Synonyms | hexadecyl 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Treprostinil is used to treat certain kinds of pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness).
The listed CAS number is 1706528-83-7.
The listed molecular formula is C39H66O5.
The listed molecular weight is 614.9 g/mol.
hexadecyl 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetate.
The source lists Hexadecyl treprostinil and treprostinil hexadecyl ester.